Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

COVIDITY-001 study of SCOV-1 and SCOV-2 vaccine candidates approved in South Africa

July 30, 2021

Daewoong reports phase IIb topline data on Foistar in mild COVID-19

July 29, 2021

Venatorx reports phase I data on beta-lactamase inhibitor VNRX-7145

July 29, 2021

Selinexor shows antiviral and the anti-inflammatory effects in models of SARS-CoV-2 infection

July 29, 2021

MMV-688533 shows excellent single-dose efficacy in P. falciparum-infected mouse model

July 29, 2021

DiosCURE enters licensing agreement for single-domain antibodies against SARS-CoV-2

July 28, 2021

JadiCell reduces lung injury in animal model replicating COVID-19 Delta variant inflammation

July 28, 2021

Clinical trial of AP-003 in COVID-19 approved in Chile

July 28, 2021

Inhalable human ACE2-containing nanocatchers may protect host cells from SARS-CoV-2 infection

July 27, 2021

Ophirex initiates phase II study of varespladib in severe COVID-19

July 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...